- Description
- Benefits
- Risks
- Additional information
- Research
Description
Ipamorelin is a selective synthetic pentapeptide classified as a growth hormone releasing peptide (GHRP). It is widely studied in laboratory environments for its role in growth hormone (GH) secretion, ghrelin receptor activation, and endocrine signalling pathways.
In controlled research settings, Ipamorelin acts as a selective agonist of the growth hormone secretagogue receptor (GHS-R), stimulating growth hormone release from the pituitary gland with a focus on targeted GH pathway activation.
Unlike earlier GHRPs, Ipamorelin is often investigated for its selectivity in GH release, making it a key compound in research exploring hormonal precision, metabolic regulation, and neuroendocrine signalling.
Across Ireland and Europe, Ipamorelin is commonly studied in areas including:
- Growth hormone secretion and regulation
- Ghrelin receptor (GHS-R) activation
- Endocrine and neuroendocrine system research
- Metabolic and energy regulation pathways
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – Ipamorelin
| Specification | Details |
|---|---|
| Product Name | Ipamorelin |
| Compound Type | Synthetic pentapeptide |
| Functional Class | Growth hormone releasing peptide (GHRP) |
| Mechanism of Action | Selective ghrelin receptor (GHS-R) agonist |
| Biological Targets | Pituitary gland, GHS-R receptors |
| Amino Acid Length | 5 amino acids |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Further Refrences: PubChem Entry
Researched Benefits & Focus Areas – Ipamorelin
1. Growth Hormone (GH) Release Research
Ipamorelin has been studied for:
- Selective stimulation of endogenous GH release
- Investigation of pituitary gland signalling pathways
- Analysis of controlled hormonal secretion patterns
Reference basis: Derived from endocrinology and pharmacology research examining growth hormone releasing peptides and receptor-specific activation.
2. Ghrelin Receptor (GHS-R) Activation
Research has explored:
- Binding to growth hormone secretagogue receptors
- Targeted activation of ghrelin signalling pathways
- Reduced interaction with non-target receptors (research context)
Reference basis: Based on biochemical studies investigating receptor selectivity in peptide-receptor interactions.
3. Endocrine System Precision & Regulation
Ipamorelin is used in:
- Research into precise hormonal modulation
- Investigation of the GH/IGF-1 axis
- Studies on neuroendocrine signalling systems
Reference basis: Supported by clinical and preclinical studies examining endocrine regulation and GH pathway control.
4. Metabolic & Energy Regulation Research
- Studied for its role in metabolic signalling pathways
- Explored in energy utilisation and regulation models
- Investigated for interaction with growth-related metabolic systems
Reference basis: Derived from research into ghrelin signalling and metabolic pathway regulation.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – Ipamorelin
1. Hormonal System Influence
- May significantly affect growth hormone levels
- Potential for endocrine imbalance in research models
Reference basis: Based on studies examining GH regulation and hormonal feedback systems.
2. Receptor Interaction Complexity
- May interact with multiple signalling pathways
- Potential for variable responses in experimental conditions
Reference basis: Derived from research into peptide-receptor binding and signalling interactions.
3. Off-Target Biological Effects
- Possible influence on non-target biological systems
- Broad interaction across neuroendocrine pathways
Reference basis: Based on studies highlighting interconnected signalling systems.
4. Limited Long-Term Research
- Lack of extensive long-term data
- Primarily studied in controlled laboratory environments
Reference basis: Reflects the current stage of growth hormone peptide research.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS